Cargando…
Development of a peptide targeting dopamine transporter to improve ADHD-like deficits
Attention-deficit hyperactivity disorder (ADHD) is a neurocognitive disorder characterized by hyperactivity, inattention, working memory deficits and impulsivity. Its worldwide prevalence is estimated to be 3–5% in children and adolescents. The mainstay treatment for ADHD is stimulant medications (e...
Autores principales: | Lai, Terence K. Y., Su, Ping, Zhang, Hailong, Liu, Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6234781/ https://www.ncbi.nlm.nih.gov/pubmed/30413217 http://dx.doi.org/10.1186/s13041-018-0409-0 |
Ejemplares similares
-
PT545. The Direct Protein-Protein Interaction between Dopamine Transporter and Dopamine D2 Receptor: A Novel Target Site to Modulate Synaptic Dopamine
por: Lai, Terence K.Y., et al.
Publicado: (2016) -
Motivation Deficit in ADHD is Associated with Dysfunction of the Dopamine Reward Pathway
por: Volkow, Nora D., et al.
Publicado: (2010) -
Targeting dopamine transporter to ameliorate cognitive deficits in Alzheimer's disease
por: Shaikh, Ammara, et al.
Publicado: (2023) -
Serotonin and Dopamine Blood Levels in ADHD-Like Dogs
por: González-Martínez, Ángela, et al.
Publicado: (2023) -
ADHD in adolescence and adulthood, with a special focus on the dopamine transporter and nicotine
por: Krause, Johanna, et al.
Publicado: (2006)